They also found that tumor-infiltrating immune cells in UM samples contained CD8+ T cells, which had not been previously recognized, and that they mainly expressed the checkpoint marker LAG3 rather than PD1 or CTLA4. The gene discussed is CTLA4; the disease is neoplasm.